0001209191-15-058217.txt : 20150701 0001209191-15-058217.hdr.sgml : 20150701 20150701183700 ACCESSION NUMBER: 0001209191-15-058217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150701 DATE AS OF CHANGE: 20150701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORTHOFIX INTERNATIONAL N V CENTRAL INDEX KEY: 0000884624 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 ABRAHAM DE VEERSTRAAT STREET 2: CURACAO CITY: NETHERLANDS ANTILLES STATE: P8 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finegan Michael CENTRAL INDEX KEY: 0001391402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19961 FILM NUMBER: 15966583 MAIL ADDRESS: STREET 1: 3451 PLANO PARKWAY CITY: LEWISVILLE STATE: TX ZIP: 75056 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-30 0 0000884624 ORTHOFIX INTERNATIONAL N V OFIX 0001391402 Finegan Michael 3451 PLANO PARKWAY LEWISVILLE TX 75056 0 1 0 0 Chief Strategy Officer Common Stock 2015-06-30 4 A 0 4050 0.00 A 64292 D Common Stock 2015-06-30 4 A 0 8100 0.00 A 72392 D Stock Option (right to buy) 33.12 2015-06-30 4 A 0 12150 0.00 A 2025-06-30 Common Stock 12150 12150 D Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 30, 2015. Represents performance-based vesting restricted stock. Under the terms of the grant, 50% of the restricted stock will vest if the Company achieves Adjusted EBITDA of $78.5 million or greater in any of the 2016, 2017 or 2018 fiscal years, and (ii) 50% will vest if the Company achieves ROIC of 12.2% or greater in any of the 2016, 2017 or 2018 fiscal years. In the event that the Adjusted EBITDA criteria and/or ROIC criteria is not achieved, pro rata vesting of 50-100% of that portion of the award will occur if 2018 fiscal year Adjusted EBITDA is between $74.6 million and $78.5 million and/or ROIC is between 11.6% and 12.2%. As part of the grant, recipient has also received a performance right that entitles the recipient to receive additional shares of common stock (ranging from 0-50% of the amount of shares of restricted stock currently being granted) if 2018 fiscal year Adjusted EBITDA is between $78.5 million and $86.4 million and/or 2018 fiscal year ROIC is between 12.2% and 13.5%. These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 30, 2015. /s/ Jeffrey M. Schumm, by power of attorney 2015-07-01